CRISPR gene editing reveals new therapeutic approach for blood disorders
An international team of scientists has found a way to use CRISPR gene editing to help fix sickle cell disease and beta-thalassemia in blood cells isolated from patients.
An international team of scientists has found a way to use CRISPR gene editing to help fix sickle cell disease and beta-thalassemia in blood cells isolated from patients.
Leave a Reply